Prognostic Significance of SATB1, SMAD3, Ezrin and β-Catenin in Patients with Pancreatic Adenocarcinoma
Authors:
- Justyna DurślewiczJustyna Durślewicz
- Anna Klimaszewska-WiśniewskaAKAnna Klimaszewska-Wiśniewska
- Ewa DomanowskaEDEwa Domanowska
- Natalia Skoczylas-MakowskaNSNatalia Skoczylas-Makowska
- Paulina AntosikPAPaulina Antosik
- Wioletta ZielińskaWioletta Zielińska
- Arkadiusz GzilAGArkadiusz Gzil
- Paulina CzajkowskaPCPaulina Czajkowska
- Klaudia MikołajczykKMKlaudia Mikołajczyk
- Dariusz GrzankaDGDariusz Grzanka
Open Access
- 29 December 2021
- journal article
- research article
- Published by MDPI AG in Applied Sciences
- Vol. 12 (1) , 306
Abstract
The present study aimed to explore the role of SATB1, SMAD3, Ezrin and β-catenin as individual and combined biomarkers for the survival prediction in pancreatic adenocarcinoma (PAC). Notably, this study distinguished for the first time a potential prognostic value of SATB1 corresponding to its subcellular localization in PAC. Immunohistochemical staining on tissue macroarrays, as well as RNA-seq data from public sources, were investigated, and the results correlated with overall survival (OS) and clinicopathological features. The connectivity between the examined factors, as well as their common signaling pathways, were demonstrated by the functional enrichment analysis. Herein, the prognostic ability of cytoplasmic SATB1 in OS analysis was even superior to nuclear SATB1. Both staining patterns tended to have opposite roles in the prognosis of PAC: SATB1c was an independent prognostic factor for poor OS, whereas SATB1n expression reached no statistical significance, but Kaplan–Meier curves separated patients with low expression and adverse prognosis from patients with high expression and favorable prognosis. High levels of SATB1 mRNA appeared as an independent prognostic indicator for better OS. Furthermore, individual expression of SMAD3 or Ezrin, as well as combined expression of SATB1/SMAD3/Ezrin/β-catenin, were associated with OS independently of conventional risk factors, both in our cohort and TCGA dataset. In our series, patients with tumors harboring combined expression of SATB1n-high/SMAD3low/Ezrinlow/β-cateninlow experienced the highest survival rates, while those with SATB1c-present/SMAD3high/Ezrinhigh/β-cateninhigh had the worst survival. In conclusion, protein and/or mRNA expression levels of SATB1, SMAD3, Ezrin and β-catenin may serve as potential prognostic biomarkers for PAC, both as single predictors and even better when combined.Keywords
Funding Information
- Uniwersytet Mikolaja Kopernika w Toruniu (MN-1/WL/2019)
This publication has 54 references indexed in Scilit:
- RETRACTED: Upregulation of SATB1 Is Associated with Prostate Cancer Aggressiveness and Disease ProgressionPLOS ONE, 2013
- Molecular correlates and prognostic significance of SATB1 expression in colorectal cancerDiagnostic Pathology, 2012
- Upregulation of SATB1 is associated with the development and progression of gliomaJournal of Translational Medicine, 2012
- KEGG for integration and interpretation of large-scale molecular data setsNucleic Acids Research, 2011
- Ezrin promotes invasion and metastasis of pancreatic cancer cellsJournal of Translational Medicine, 2010
- Global Regulator SATB1 Recruits β-Catenin and Regulates TH2 Differentiation in Wnt-Dependent MannerPLOS Biology, 2010
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Common Activation of Canonical Wnt Signaling in Pancreatic AdenocarcinomaPLOS ONE, 2007
- Aberrant Wnt/β-Catenin Signaling in Pancreatic AdenocarcinomaNeoplasia, 2006
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003